Literature DB >> 8267912

The assumption of no long reporting delays may result in underestimates of US AIDS incidence.

P C Cooley1, D N Hamill, L E Myers, E C Liner.   

Abstract

OBJECTIVE: To evaluate the effect of the assumption of no long reporting delays on estimates of AIDS incidence.
DESIGN: Reported AIDS cases must be adjusted for reporting delays to estimate AIDS incidence. We compared the adjustments supplied with the Centers for Disease Control and Prevention (CDC) AIDS Public Information Data Set with a set of adjustments that differ with respect to CDC assumption of no long delays. Both methods assume that no changes in delay have occurred throughout the reporting period.
METHODS: Probability distributions of reporting delays were calculated from the delay adjustment weights supplied by CDC, and from an alternative method that estimates the probability of long delays from the surveillance data. AIDS incidence estimates from these two approaches were calculated and compared.
RESULTS: The CDC adjustments assume that there will be no reporting delays longer than 61 months, whereas the alternative method estimates that 5.9% of case reports will be delayed longer than 61 months. The CDC adjustments result in lower estimates of AIDS incidence and a flattening of the epidemic.
CONCLUSIONS: In addition to a 6.2% reduction in total estimated AIDS incidence, the CDC assumption changes the shape of the estimated epidemic. These may result in as much as 4-21% reductions in model estimates of HIV incidence and prevalence.

Entities:  

Mesh:

Year:  1993        PMID: 8267912     DOI: 10.1097/00002030-199310000-00012

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  2 in total

1.  Trends of AIDS incidence in Europe and the United States.

Authors:  L Dal Maso; S Franceschi; E Negri; D Serraino; C La Vecchia; R A Ancelle-Park
Journal:  Soz Praventivmed       Date:  1995

2.  A change-point model for reporting delays under change of AIDS case definition.

Authors:  F Tabnak; H G Müller; J L Wang; J M Chiou; R K Sun
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.